Google parent company Alphabet Inc. has launched a new company in London called Isomorphic Labs. The company aims to use AI (artificial intelligence) for drug discovery and medicine to find cures for some of humanity’s most devastating diseases. Demis Hassabis will be the CEO of Isomorphic Labs. Hassabis is the CEO and co-founder of DeepMind, another Alphabet subsidiary that used AI to predict the 3D structure of a protein directly from its amino acid sequence.
The London-based Isomorphic Labs will work on the most important applications of AI — in the field of biological and medical research. The company aims to use AI to accelerate drug discovery, and ultimately, find cures for some of humanity’s most devastating diseases. The new venture also plans to partner with biomedical and pharmaceutical companies, using artificial intelligence to discover new medicinal advancements.
Important takeaways for all competitive exams
The ICC U19 Women’s T20 World Cup 2027 is set to commence on January 21,…
Iodine Deficiency Day or World Iodine Deficiency Disorders Prevention Day is celebrated on October 21…
There is an imported case of the Bundibugyo strain of the Ebola virus in the…
On October 21, 2026, the Drugs Controller General of India (DCGI) approved Zytorvi (toripalimab) in…
India was ranked third in the Ipsos Quality of Care Perception Index 2026 after Malaysia…
Jamnagar is a coastal city in the state of the Gujarat and it is emerging…